Evaluation and Management of Constipation in Adults Without Red-Flag Symptoms
Start with a trial of polyethylene glycol (PEG) 17g daily or psyllium fiber 15g daily, combined with lifestyle modifications including 25-30g total daily fiber intake and adequate hydration, before considering specialized testing or newer pharmacological agents. 1, 2
Initial Evaluation
Perform a focused assessment that includes:
- Digital rectal examination with assessment of pelvic floor motion during simulated evacuation to identify defecatory disorders 3
- Medication review to identify constipating agents (opioids, anticholinergics, calcium channel blockers) 4
- Complete blood count only - metabolic panels (glucose, calcium, TSH) are not recommended unless other clinical features warrant them 3
- Colonoscopy only if age-appropriate screening has not been performed; otherwise not indicated without alarm features 3
Key point: A normal digital rectal examination does not exclude defecatory disorders, but a careful examination is essential before proceeding to anorectal manometry 3.
First-Line Management
Dietary and Lifestyle Modifications
- Gradually increase dietary fiber to 25-30g daily for mild to moderate constipation 2
- Among fiber supplements, psyllium is the only one with proven efficacy 1
- Ensure adequate hydration with fiber supplementation 1
- Consider magnesium-rich mineral water as an adjunct 2
Caution: High-fiber diets can worsen symptoms in some patients with chronic constipation, particularly those with slow transit 5. If bloating or distension worsens, reduce fiber and proceed to osmotic laxatives.
Pharmacological First-Line Therapy
PEG (polyethylene glycol) is the recommended first-line osmotic laxative with strong evidence supporting its use 1:
- Dose: 17g (one capful) daily in 8oz water
- Response is durable over 6 months
- Side effects: abdominal distension, loose stools, flatulence, nausea
- Cost: approximately $1/day 3
Alternative osmotic agents if PEG unavailable:
- Milk of magnesia 30-60mL daily
- Lactulose 30-60mL daily 6
Second-Line Management (If First-Line Fails)
Add Stimulant Laxatives
- Bisacodyl 2-3 tablets daily or suppository 6
- Senna (sennosides) - stimulates myenteric plexus in colon 6
- Glycerin suppositories - administer 30 minutes after a meal to synergize with gastrocolonic response 3
Important: Stimulant laxatives should be avoided if intestinal obstruction is suspected 6.
Third-Line Management (Refractory to Laxatives)
Newer Pharmacological Agents
Consider when symptoms persist despite adequate trials of fiber and osmotic/stimulant laxatives 1:
- Linaclotide - prosecretory agent
- Lubiprostone - chloride channel activator
- Prucalopride - 5-HT4 receptor agonist (not available in US but approved elsewhere) 3
Cost: $7-9/day for these agents 3
When to Pursue Specialized Testing
Colonic transit testing should be performed only if 3, 4:
- Anorectal testing does not show a defecatory disorder, OR
- Symptoms persist despite treatment of a confirmed defecatory disorder
Anorectal manometry and balloon expulsion testing should be considered if 7:
- History and examination suggest defecatory disorder (sensation of blockage, need for manual maneuvers)
- Patient fails fiber and laxative trials
If defecatory disorder confirmed: Biofeedback therapy improves symptoms in >70% of patients and is the treatment of choice 3, 1.
Management Algorithm Summary
- Rule out secondary causes (medications, check CBC only)
- Start PEG 17g daily + gradual fiber increase to 25-30g/day
- If inadequate response after 4-6 weeks: Add stimulant laxative (bisacodyl or senna)
- If still refractory: Consider newer agents (linaclotide, lubiprostone, prucalopride)
- If no response to pharmacotherapy: Pursue anorectal testing for defecatory disorder
- If defecatory disorder confirmed: Biofeedback therapy
- If normal anorectal function: Check colonic transit time
Common Pitfalls to Avoid
- Do not order extensive metabolic testing (calcium, TSH, glucose) routinely - only CBC is recommended 3
- Do not perform colonoscopy without alarm features or if age-appropriate screening is current 3
- Do not use bulk-forming agents like Metamucil for opioid-induced constipation - they are ineffective in this context 8
- Do not delay assessment for defecatory disorders - these require biofeedback, not escalating laxatives 3
- Do not proceed to colonic transit testing before ruling out defecatory disorders 4
Special Consideration: Opioid-Induced Constipation
If patient is on opioids, standard laxatives often fail. Consider 8:
- Prophylactic regimen: Senna + docusate from opioid initiation
- If refractory: Methylnaltrexone 0.15mg/kg subcutaneously
- Note: Fiber supplements are unlikely to control opioid-induced constipation 8